tolbutamide has been researched along with Hyperparathyroidism, Secondary in 1 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasuda, K | 1 |
| Hurukawa, Y | 1 |
| Okuyama, M | 1 |
| Kikuchi, M | 1 |
| Yoshinaga, K | 1 |
1 other study available for tolbutamide and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release.
Topics: Calcium; Glucose Tolerance Test; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypopa | 1975 |